Recombinant human erythropoietin(rhepo) (DrugBank: Erythropoietin)
10 diseasesID | Disease name (Link within this page) | Number of trials |
---|---|---|
2 | Amyotrophic lateral sclerosis | 1 |
6 | Parkinson disease | 0 |
13 | Multiple sclerosis/Neuromyelitis optica | 0 |
18 | Spinocerebellar degeneration | 0 |
22 | Moyamoya disease | 0 |
46 | Malignant rheumatoid arthritis | 0 |
47 | Buerger disease | 0 |
70 | Spinal stenosis | 0 |
95 | Autoimmune hepatitis | 0 |
96 | Crohn disease | 0 |
No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | NCT03835507 (ClinicalTrials.gov) | June 20, 2016 | 8/8/2018 | Randomized, Double-blind, Safety and Efficacy of Recombinant Human Erythropoietin in Amyotrophic Lateral Sclerosis | Randomized, Double-blind, Safety and Efficacy of Recombinant Human Erythropoietin in Amyotrophic Lateral Sclerosis | Amyotrophic Lateral Sclerosis | Drug: recombinant human erythropoietin(rhEPO) | Hanyang University Seoul Hospital | NULL | Recruiting | 25 Years | 80 Years | All | 64 | Phase 1;Phase 2 | Korea, Republic of |